Literature DB >> 10629675

Occult bacteremia in young febrile children.

N Kuppermann1.   

Abstract

The evaluation of nontoxic-appearing, young, febrile children has been a subject of considerable debate. Of young, nontoxic-appearing children aged 3 to 36 months with temperatures of 39 degrees C or more and no clear source, approximately 2% to 3% have occult bacteremia. Of these bacteremias, approximately 90% are caused by S. pneumoniae, 5% by nontyphoidal Salmonella sp., and 1% by N. meningitidis. Most children with occult pneumococcal bacteremia improve spontaneously, but approximately 25% of untreated patients have persistent bacteremia or develop new focal infections, including 3% to 6% who develop meningitis. Occult meningococcal bacteremia, although rare, has frequent complications, including meningitis in approximately 40% and death in approximately 4%. Less is known about the natural history of untreated occult nontyphoidal Salmonella bacteremia. Empiric antibiotic treatment of children with occult bacteremia decreases the rate of complications, including meningitis. Few disagree that febrile, young children at risk for occult bacteremia require a careful clinical evaluation and close follow-up. The benefits of laboratory screening and selective empiric antibiotic treatment of febrile children at risk for occult bacteremia have to be weighed against the costs of screening tests and blood cultures, inconvenience, temporary discomfort to patients, risk for side effects of antibiotics, and the role of antibiotics in the development of bacterial resistance. Although great debate exists concerning the role of empiric antibiotics, a strategy for obtaining blood cultures and empirically administering antibiotics on the basis of an increased ANC, in addition to close clinical follow-up, may be effective in reducing the frequency and severity of uncommon but adverse sequelae. A highly effective S. pneumoniae bacterial conjugate vaccine will soon be available, which will benefit all children, and will alter the ways that clinicians evaluate fully immunized young, febrile children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10629675     DOI: 10.1016/s0031-3955(05)70176-0

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  18 in total

Review 1.  Glycoconjugate vaccine strategies for protection against invasive Salmonella infections.

Authors:  Raphael Simon; Myron M Levine
Journal:  Hum Vaccin Immunother       Date:  2012-02-28       Impact factor: 3.452

2.  Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium.

Authors:  Thomas B Clarke; Nicholas Francella; Alyssa Huegel; Jeffrey N Weiser
Journal:  Cell Host Microbe       Date:  2011-05-19       Impact factor: 21.023

3.  Passive cigarette smoke exposure and other risk factors for invasive pneumococcal disease in children: a case-control study.

Authors:  Colleen S Chun; Sheila Weinmann; Karen Riedlinger; John P Mullooly
Journal:  Perm J       Date:  2014-11-24

4.  How do blood cultures sent from a paediatric accident and emergency department influence subsequent clinical management?

Authors:  P Leonard; T F Beattie
Journal:  Emerg Med J       Date:  2003-07       Impact factor: 2.740

5.  Approach to the febrile child: A challenge bridging the gap between the literature and clinical practice.

Authors:  Jean-Bernard Girodias; Benoit Bailey
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

Review 6.  Meningococcal vaccines.

Authors:  Jens U Rüggeberg; Andrew J Pollard
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children.

Authors:  Penelope A Bryant; Hua Yi Li; Angelo Zaia; Julia Griffith; Geoff Hogg; Nigel Curtis; Jonathan R Carapetis
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Epidemiologic impact of blood culture practices and antibiotic consumption on pneumococcal bacteraemia in children.

Authors:  A Pérez; M Herranz; M Segura; E Padilla; F Gil; G Durán; F Ferres; A Esteve; D Blanquer; E Bernaola
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03-18       Impact factor: 3.267

9.  Toward early identification of acute lung injury in the emergency department.

Authors:  Robert J Freishtat; Bahar Mojgani; David J Mathison; James M Chamberlain
Journal:  J Investig Med       Date:  2007-12       Impact factor: 2.895

10.  Accuracy of Complete Blood Cell Counts to Identify Febrile Infants 60 Days or Younger With Invasive Bacterial Infections.

Authors:  Andrea T Cruz; Prashant Mahajan; Bema K Bonsu; Jonathan E Bennett; Deborah A Levine; Elizabeth R Alpern; Lise E Nigrovic; Shireen M Atabaki; Daniel M Cohen; John M VanBuren; Octavio Ramilo; Nathan Kuppermann
Journal:  JAMA Pediatr       Date:  2017-11-06       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.